Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

mTORC1 activity is important for hair growth and color, and targeting it could help treat hair loss and greying.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

High-dose ciclosporin significantly improved a young cat's severe skin condition.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Ciclosporin might be a good alternative treatment for certain hearing loss that responds to steroids.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Minoxidil and oral antioxidants helped improve hair growth in a patient with hair loss due to lupus.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Cyclosporine can treat skin conditions but needs careful monitoring for side effects.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

CS12192 effectively treats alopecia areata with better safety than current options.

New treatments for lupus show promise, but more research is needed, especially for children.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The document concludes that DNA methylation and the mTOR pathway are important for stem cell function and could impact disease treatment.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.